Testing the proportional hazards assumption in case-cohort analysis. - Wikidata - awgldk - TriplyDB

Testing the proportional hazards assumption in case-cohort analysis.

Testing the proportional hazards assumption in case-cohort analysis.

http://www.wikidata.org/entity/Q34802658

about

The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabetics Improving efficiency of parameter estimation in case-cohort studies with multivariate failure time data.A review of published analyses of case-cohort studies and recommendations for future reporting.A new comparison of nested case-control and case-cohort designs and methods A method making fewer assumptions gave the most reliable estimates of exposure-outcome associations in stratified case-cohort studies Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study Urinary Cadmium and Risk of Invasive Breast Cancer in the Women's Health Initiative.Cumulative Resting Heart Rate Exposure and Risk of All-Cause Mortality: Results from the Kailuan Cohort Study.Aortic Atheroma Increases the Risk of Long-Term Mortality in 20,000 Patients.Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study.Calcification of the splenic, iliac, and breast arteries and risk of all-cause and cardiovascular mortality.Comparison and combination of blood DNA methylation at smoking-associated genes and at lung cancer-related genes in prediction of lung cancer mortality.Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg.Complete hazard ranking to analyze right-censored data: An ALS survival study.Estrogen receptor quantitative measures and breast cancer survival.Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.Breast cancer survival, survival disparities, and guideline-based treatment.Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohort.A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.

P2860

Q28277713-F010A267-790D-4EF4-943A-8A61D73CE469 Q31155939-BCB325DC-4280-4F63-BE43-1F596DDA6C52 Q35196492-7FF7636C-82AD-4B6F-B700-536F130DE40C Q35217759-66B54DAC-7590-46C2-BEED-4E051916FC2D Q36345777-A11046BF-6420-49B7-A53B-633DA507C512 Q36513866-4AA78733-0F0D-4E85-81E0-2D6C2AD762C4 Q36854269-E40A7E05-2B58-40AC-80F7-1D449C5FF1C6 Q37571010-AE56FF5C-E333-4344-B635-47C2E478CEA3 Q38746840-8C24E7FB-920B-4C54-BE45-72512D85458E Q40045667-DE3D9EF3-CC94-4C01-9D18-0BB37BFDF873 Q40328104-2583485C-C3BA-4962-82F9-66B10FEEE43E Q40630283-2C83DC8D-3A33-4A8E-8E76-0DEF40A476E7 Q41461029-40FB6CF6-2BF5-4974-832A-5EC0813A50FD Q47238514-A5EC01F3-FF64-4E8A-BE24-D4C807C9240E Q47928157-65F275FC-CDAB-4B17-9082-B3AD55EA9BDC Q49286468-69A1DF5F-736B-4FAA-A92E-0D274566942D Q52641223-4F5B6494-89D7-4157-A1FD-C8CC5F3F3934 Q52668761-CBA33765-544B-4599-89CF-2C13A1D6999E Q52873877-57945E32-CF30-4C7B-8917-F4D80B460887

P2860

Testing the proportional hazards assumption in case-cohort analysis.

http://www.wikidata.org/entity/Q34802658

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Testing the proportional hazards assumption in case-cohort analysis.

@ast

Testing the proportional hazards assumption in case-cohort analysis.

@en

Testing the proportional hazards assumption in case-cohort analysis.

@nl

type

label

Testing the proportional hazards assumption in case-cohort analysis.

@ast

Testing the proportional hazards assumption in case-cohort analysis.

@en

Testing the proportional hazards assumption in case-cohort analysis.

@nl

prefLabel

Testing the proportional hazards assumption in case-cohort analysis.

@ast

Testing the proportional hazards assumption in case-cohort analysis.

@en

Testing the proportional hazards assumption in case-cohort analysis.

@nl

P1433

Q34802658-24B8CBD2-E775-4D9D-B1A0-B58691FBA05C

P1476

Q34802658-2F5D8495-DA17-489D-80EB-2AB11509701D

P2093

Q34802658-0147F1AD-D1BD-4F63-A7B7-0B307F6DD4B4

Q34802658-20799BCE-C618-4881-9761-DD53DC4CDECD

Q34802658-21509DDB-C6DD-4684-A4C1-2EFA90BEEDD1

Q34802658-365840E0-6CF5-40BB-8344-BFDBB6DA5AF7

Q34802658-5E84AA37-274D-4A92-9001-BA24FD4E6A33

Q34802658-83BD0D27-469B-43A5-A7CF-2753642B948E

Q34802658-A1302B81-5988-416F-8961-C1F31F515995

Q34802658-C65A5DC9-CE01-4784-A192-CF410E3471C5

P2860

Q34802658-00CB60F5-A9CC-4A01-9743-3ABD6595FDD8

Q34802658-0850BEC4-0213-4EE4-B2A1-929F2C40BD12

Q34802658-13EF416F-F87B-48EC-81E9-586E666CCA6D

Q34802658-1B508ADB-344B-4806-9778-2A247FFD69C7

Q34802658-29133668-EF69-4E90-A40C-CC0DD42DFE6A

Q34802658-379031F4-0D6F-42EF-96EC-FFC01F936096

Q34802658-4B8CA998-AA68-4C73-8365-127DA647BCBA

Q34802658-52B99547-7ABD-4716-81B9-3C993DA33364

Q34802658-6F843758-852C-4C6F-A4D9-3CCDCD53FC0E

Q34802658-A8C7B6FA-31F7-4200-8B72-B57A8E7A53F2

P2888

Q34802658-C0517C60-595B-4D06-8E90-294BDAC38713

P304

Q34802658-3FADBEBC-CF8C-4B49-AE88-3AB381A65BE6

P31

Q34802658-D897BEEC-2A3E-4864-9CDA-B6ABDAA83B55

P356

Q34802658-37DBBE16-96BA-4078-ADE3-C6BF93A6BB07

P478

Q34802658-1A52046C-151D-4C76-9741-A4D9EE32DF44

P50

Q34802658-03490FEE-96D1-4C2D-802C-ED14D03E2C1A

P577

Q34802658-BAE36AD0-B3C9-4DA2-82C8-0F8DDE25E3A1

P5875

Q34802658-17C33082-FF2E-48CF-93C5-EE40F0A73B41

P6179

Q34802658-9E1B9267-D424-4B42-B01F-676F48CB214C

P698

Q34802658-6F30783C-F2EB-435D-B714-CD0A84823619

P932

Q34802658-1A1E7B7B-1B8B-4BEB-9E3E-68BFB3C90EB0

P356

1471-2288-13-88

P1433

BMC Medical Research Methodology

P1476

Testing the proportional hazards assumption in case-cohort analysis.

@en

P2093

Dominic Cirillo

http://www.w3.org/2001/XMLSchema#string

Gloria Y F Ho

http://www.w3.org/2001/XMLSchema#string

Herbert Yu

http://www.w3.org/2001/XMLSchema#string

Howard D Strickler

http://www.w3.org/2001/XMLSchema#string

Marc Gunter

http://www.w3.org/2001/XMLSchema#string

Thomas E Rohan

http://www.w3.org/2001/XMLSchema#string

Xianhong Xie

http://www.w3.org/2001/XMLSchema#string

Xiaonan Xue

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods in cancer epidemiological studies

Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer

Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.

Additive hazard regression models: an application to the natural history of human papillomavirus.

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.

Conventional case-cohort design and analysis for studies of interaction.

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

Exposure stratified case-cohort designs.

Robust variance estimation for the case-cohort design.

P2888

1471-2288-13-88

P304

88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2288-13-88

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Sylvia Wassertheil-Smoller

P577

2013-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

247771043

http://www.w3.org/2001/XMLSchema#string

P6179

1001153978

http://www.w3.org/2001/XMLSchema#string

P698

23834739

http://www.w3.org/2001/XMLSchema#string

P932

3710085

http://www.w3.org/2001/XMLSchema#string